OTC: SFOSF - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Yield per half year: 0%
Dividend yield: +2.26%
Sector: Healthcare

Reporting Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Capitalization

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд $
8.2 7.1 10.75 12.9 7.33 7.53 11.91 12.09 12.5 9.7
Выручка, млрд $
12.61 14.63 18.53 24.92 28.59 30.31 39.01 6.08 5.64 5.89
Чистая прибыль, млрд $
2.46 2.81 3.12 2.71 3.32 3.66 4.74 0.516 0.325 0.3393
EV, млрд $
15.41 13.03 24.37 16.15 16.28 11.99 17.31 10.03 26.09 27.24
EBIT, млрд $
3.92 4.14 4.62 2.13 2.31 2.37 2.25 1.15 0.7339 0.7661
EBITDA, млрд $
4.02 4.3 5.58 5.83 7.07 7.23 8.71 1.47 1.14 1.19
Баланс стоимость, млрд $
18.18 22.19 25.33 26.68 30.89 33.46 34.63 6.17 44.18 46.12
FCF, млрд $
0.385 0.188 0.41 -0.225 -0.74 -1.86 -1.02 -0.2311 -0.2619 -0.2734
Операционный денежный поток, млрд $
1.62 2.11 2.58 2.81 3.12 2.33 3.49 0.5833 0.4651 0.4855
Операционная прибыль, млрд $
1.47 1.74 2.3 2.37 2.62 2.83 2.72 0.644 0.4505 0.4703
Операционные расходы, млрд $
11.21 12.89 16.23 22.55 25.97 27.48 32.06 2.37 2.48 2.59
CAPEX, млрд $
1.24 1.92 2.17 3.18 3.96 4.44 4.97 0.8145 0.7269 0.7589


Balance sheet

IFRS
Reporting Annual Quarterly
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд $
4.03 6 7.25 9.16 9.99 11.93 9.11 2.25 13.24 13.82
Short Term Investments $
0.0338 0.0485 0.2193 0.5803 0.4369 1.76 3.7 0.1284 1.83 1.91
Long term investments $
11.6 14.4 17.23 18.85 21.12 24.06
Total Receivables $
2.52 2.98 4.52 4.53 5.26 5.17 6.58 1.49 9.64 10.06
Total Current Assets $
8.33 10.76 15.06 16.95 19.52 22.41 26.55 4.88 32.68 34.12
Чистые активы, млрд $
5.76 6.3 8.32 17.17 19.77 22.69 26.88 2.22 4.88 4.92
Активы, млрд $
38.2 43.77 61.97 70.55 76.12 83.69 82.44 14.82 109.74 114.56
Short Term Debt $
7.33 5.65 10.48 1.47 6.08 7.07 8.22 2.41 18.91 19.74
Long Term Debt $
3.9 6.28 10.39 13.09 12.27 7.57 7.9 1.67 13.06 13.63
Задолженность, млрд $
17.53 18.52 32.23 36.96 36.92 37.7 39.69 7.34 54.98 57.4
Чистый долг, млрд $
6.88 5.23 13.04 9.28 9.11 5.82 7.21 1.94 20.71 21.62
Долг, млрд $
11.24 11.93 20.87 18.28 18.94 16.39 3.38 4.18 33.95 33.37
Interest income $
0.0809 0.0792 0.1457 0.1866 0.1996 0.2337 0.2826 0.3636
Расходы на обслуживание долга $
0.47 0.4882 0.5775 0.8866 0.881 0.8225 0.9638 0.1333 0.1805 0.1884
Чист. проц. доходы, млрд $
-0.4308 -0.5245 0.139 0.1808 0.1805 0.2065 0.0397 0.0511 0.0511
Goodwill $
3.26 3.3 3.47 8.46 8.85 9.01 8.68 9.4 10.34 10.85
Амортизация, млрд $
0.6493 0.7329 0.9386 1.32 0.2053 0.2324 0.2559 0.3231 0.4039 0.4216
Себестоимость, млрд $
6.31 6.72 7.61 10.37 11.54 13.43 20.23 3.2 2.94 3.07
Товарно материальные запасы $
1.65 1.67 2.75 3.29 3.94 5.16 4.78 0.9519 7.29 7.61


Share

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS 1.06 1.2 1.27 1.07 1.3 1.43 1.85 0.1979 0.1218 0.1271
Цена акции ао 3.18 6.49 2.87 2.94 4.66 3.11 2.19 1.7 1.7 1.7
Число акций ао, млн 2371.35 2419.03 2518.69 351 2555 2561 2556 360.62 363.64 379.62
FCF/акцию 0.1626 0.0777 0.1626 -0.6032 -2.02 -4.73 -2.55 -0.641 -0.7201 -0.7202


Efficiency

IFRS
Reporting Annual Quarterly
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 14.12 13.9 13.15 10.16 11.1 10.63 12.43 8.91 1.29 0.7357 18.23
ROA, % 6.69 6.85 5.91 4.09 4.53 4.58 5.35 3.72 0.5229 0.2962 6.96
ROIC, % 10.5 10.15 9.02 6.96 7.73 7.38 8.39 8.27 4.45 7.62 12.84
ROS, % 11.91 8.95 8.32 8.64 8.64 8.49 5.76 5.76 5.76 5.76 12.97
ROCE, % 16.38 15.53 4.24 4.05 4.45 3.98 11.23 0.952 1.34 1.34 19.13
Ebit margin, % 22.41 17.25 19.22 18.91 13.01 13.01 13.01
Рентаб EBITDA, % 29.42 26.92 19.66 20.86 20.82 20.82 24.18 20.21 20.17 20.17 29.46
Чистая рентаб, % 11.7 11.9 12.4 9.5 9.2 9.3 7 8.49 5.76 5.76 12.97
Operation Margin, % 12.43 9.5 9.15 9.34 9.34 10.59 7.99 7.98 7.98 7.98 19.70
Чистая процентная маржа, % 20.28 17.57 19.51 19.18 16.86 10.87 11.62 12.09 12.14 10.53 18.32
Доходность FCF, % 0.1591 4.7 2.65 3.81 -1.74 -9.34 -18.41 -6.77 -17.38 -27.44


Coefficients

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
17.5 18.7 33.9 17.8 19.6 20.9 15.1 15.68 16.56 16.56 23.50
P/BV
2.4 2.7 4.1 1.8 1.7 2.4 1.8 1.08 0.0983 0.0983 4.29
P/S
3.4 3.6 6.1 2.1 1.9 2.6 2 1.33 0.9547 0.9547 3.32
P/FCF
38.35 -31.27 -9.86 -6.31 -6.33 -5.75 -42.3 -35.48 -35.48 -35.48 11.71
E/P
0.2906 0.2099 0.4194 0.3631 0.3127 0.3879 0.3406 0.035 0.035 0.035 0.34
EV/EBITDA
1.62 1.83 3.78 2.36 2.84 1.62 1.63 6.82 22.93 22.93 12.99
EV/EBIT
10.52 17.64 11.55 8.72 35.55 35.56 35.56 35.56
EV/S
1.32 1.12 0.7044 0.7758 0.7284 1.65 4.63 4.62 4.62 4.62 3.74
EV/FCF
59.5 -124.45 -27.22 -12.66 -27.75 -43.4 -99.62 -99.63 -99.63 -99.63 20.36
Debt/EBITDA
3.75 4.11 2.68 2.27 2.61 2.84 29.78 28.09 28.09 28.09 1.95
Netdebt/Ebitda
0.63 0.93 1.62 -0.24 -0.24 1.32 18.17 18.2 18.2 18.2 1.47
Debt/Ratio
0.52 0.52 0.48 0.45 0.45 0.2821 0.3094 0.2913 0.2913 0.2913 0.24
Debt/Equity
1.27 1.32 1.16 1.02 1.02 0.6775 0.7684 6.78 6.78 6.78 28.58
Debt/Net Income
6.68 8.72 6.55 6.39 4.99 8.1 104.46 98.35 98.35 98.35 3.25
Бета
0.76 -0.9492 0 0 0 -1.03
Индекс Альтмана
0.98 0.87 0.97 0.99 0.99 0 13.01 0.5208 0.5208 0.5208 3.50


Dividends

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Industry average 5 year average CAGR 5
Див.выплата, млрд
1.11 1.19 1.69 1.81 1.66 1.69 0.3293 0.3396 1.12 1.86
Дивиденд
0.32 0.0512 0.4 0.32 0.39 0.43 0.0841 0.059 0.0384 0.0384
Див доход, ао, %
11.89 0.8407 16.02 12.27 9.23 10.7 17.78 2.42 2.26 2.26 2.49
Дивиденды / прибыль, %
27 27.4 45.88 36 30.2 26.7 23.4 63.64 102.89 102.89 58.04


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2018 2019 2020 2022 2023 CAGR 5
Всего задолженность
17.92 17.43 24.87
Персонал, чел
36279 36279